Zobrazeno 1 - 10
of 87
pro vyhledávání: '"Natsuki Takaha"'
Publikováno v:
Asian Journal of Endoscopic Surgery. 16:143-146
We previously reported that probe-based confocal laser endomicroscopy using acrinol can depict cancerous nuclei. The objective of this study was to confirm the safety of acrinol in patients. For all seven patients, '50 ml' of a 0.1% acrinol and '1 ml
Autor:
Fumiya Hongo, Takashi Ueda, Natsuki Takaha, Satoshi Tamada, Tatsuya Nakatani, Tsuneharu Miki, Osamu Ukimura
Publikováno v:
International journal of urology : official journal of the Japanese Urological AssociationREFERENCES.
IMA901 is the first therapeutic vaccine for renal cell cancer (RCC). It contains multiple tumor-associated peptides (TUMAPs) that are naturally present in human cancers.In a phase I/II study, we treated a total of 10 Japanese patients with advanced R
Autor:
Tatsuya Nakatani, Takashi Ueda, Kimihiro Yano, Natsuki Takaha, Satoshi Tamada, Fumiya Hongo, Schoor Oliver, Osamu Ukimura, Tsuneharu Miki, Singh-Jasuja Harpreet
Publikováno v:
Journal of Urology. 197
Autor:
Terukazu Nakamura, Daisuke Toiyama, Saya Ito-Ueda, Osamu Ukimura, Fumiya Hongo, Takashi Ueda, Natsuki Takaha
Publikováno v:
Journal of Biomolecular Research & Therapeutics.
The X-linked Inhibitor of Apoptosis Protein (XIAP) has been associated with cell survival because it blocks caspase-mediated apoptosis. The expression of XIAP and its prognostic significance in Renal Cell Cancer (RCC) have rarely been studied. Object
Autor:
Keiji Inoue, Yusuke Nakamura, Shingo Ashida, Ryo Takata, Natsuki Takaha, Koji Okihara, Michiaki Kubo, Taro Shuin, Jun Sugimura, Yozo Ohnishi, Kenjiro Kohri, Tsuneharu Miki, Masao Yamaguchi, Koichi Matsuda, Wataru Obara, Yoshiyuki Kojima, Tomoaki Fujioka, Shoichi Sasaki, Chizu Tanikawa
Publikováno v:
Journal of Human Genetics. 58:21-26
Tamsulosin hydrochloride is one of the most potent drugs for treatment of benign prostatic hyperplasia (BPH), however, the efficacy of tamsulosin hydrochloride varies among individuals. In this study, we measured the maximum serum concentration (Cmax
Autor:
Ichiro Takeuchi, Tsuneharu Miki, Akihiro Kawauchi, Natsuki Takaha, Fumiya Hongo, Yoshihiro Sowa
Publikováno v:
Journal of Urology. 187:2215-2222
Although molecular targeted therapy has improved the clinical outcome of metastatic renal cell carcinoma, a complete response is rare and there are various side effects. Identifying novel target molecules is necessary to improve the clinical outcome
Autor:
Terukazu Nakamura, Kazuya Mikami, Koji Okihara, Natsuki Takaha, Fumiya Hongo, Tsuneharu Miki, Akihiro Kawauchi, Ichiro Takeuchi, Kazumi Kamoi
Publikováno v:
The Prostate. 72:1124-1132
BACKGROUND We previously reported that the level of high mobility group protein AT-hook 1 (HMGA1) is low in androgen-dependent prostate cancer (PCa) cells (LNCaP), but is high in androgen-independent PCa cells (DU145 and PC-3) and that HMGA1 is a str
Autor:
Kazuya Mikami, Terukazu Nakamura, Akihiro Kawauchi, Takumi Shiraishi, Natsuki Takaha, Tsuneharu Miki
Publikováno v:
International Journal of Clinical Oncology. 14:436-441
We investigated the efficacy and toxicity of a regimen consisting of paclitaxel and gemcitabine plus nedaplatin, a derivative of cisplatin (TGN) in patients with heavily pretreated cisplatin-refractory germ cell tumors (GCTs).Fifteen patients with ad
Autor:
Yong Nan Li, Akihiro Kawauchi, Toshiyuki Sakai, Koji Okihara, Tsuneharu Miki, Kazuya Mikami, Terukazu Nakamura, Natsuki Takaha, Yoichi Mizutani, Takumi Shiraishi
Publikováno v:
BJU International. 99:663-668
OBJECTIVE To measure dihydropyrimidine dehydrogenase (DPD), an enzyme involved in the metabolism of 5-fluorouracil (5-FU), expression in prostate cancer and determine whether 5-chloro-2,4-dihydroxypyridine (CDHP), a potent inhibitor of DPD, enhances
Autor:
Katsuyuki Aozasa, Tsuyoshi Takada, Kazuo Nishimura, Natsuki Takaha, Akihiko Okuyama, Masashi Nakayama, Tetsuya Takao, Kiyomi Matsumiya, Hideki Fujioka, Norio Nonomura, Yuichiro Tsujimoto, Akira Tsujimura, Yasushi Miyagawa, Kohei Kurokawa
Publikováno v:
International Journal of Urology. 13:926-931
Objective: The reported rate of erectile dysfunction after nerve-sparing prostatectomy varies according to physicians. Because exact preservation of the neurovascular bundle (NVB) solely depends on the judgment of the physician, he or she should try